Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MF tricyclic |
Synonyms | |
Therapy Description |
MF tricyclic is a COX-2 inhibitor that may reduce tumor burden and prevent metastasis in cancer (PMID: 16003752, PMID: 17213821). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MF tricyclic | MF tricyclic is a COX-2 inhibitor that may reduce tumor burden and prevent metastasis in cancer (PMID: 16003752, PMID: 17213821). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
APC inact mut | colon cancer | sensitive | MF tricyclic | Preclinical | Actionable | In a preclinical study, mouse models of colon cancer carrying an APC 716del mutation had reduced polyp formation after treatment with MF tricyclic (PMID: 23843721). | 23843721 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|